Clinical Research Site

Atlanta, Georgia 30342

5 studies enrolling now · 14 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Cataplexy, Chronic Obstructive Pulmonary Disease, Depression, Excessive Daytime Sleepiness, Excessive Sleepiness, Fibromyalgia, Hidradenitis Suppurativa, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Migraine, Narcolepsy

Studies at this site

• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — Completed
• Hidradenitis Suppurativa Study of Izokibep — Stopped early
• Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
• Study in Subjects Greater Than 40 Years of Age With COPD — Completed